eLife: evolution of publishing

Independent, not-for-profit and supported by funders, eLife improves the way research is practised and shared.
eLife's peer-review process is changing. From January 2023, eLife will no longer make accept/reject decisions after peer review. Instead, every preprint sent for peer review will be published on the eLife website as a “Reviewed Preprint” that includes an eLife assessment, public reviews, and a response from the authors (if available). When writing the eLife assessment, the editors and reviewers will use a common vocabulary to summarize the significance of the findings and the strength of the evidence reported in the preprint. Read about the new process.

eLife is committed to creating a future where a diverse, global community of researchers shares open results for the benefit of all.

From the research we publish, to the tools we build, to the people we work with, we’ve earned a reputation for quality, integrity and the flexibility to bring about real change.

We're committed to a "publish, review, curate" model for publishing and plan to achieve this transition by:

  • Peer reviewing preprints in the life sciences and medicine
  • Building technology to support this model that is open-source, readily adaptable and addresses community needs
  • Working with scientists from around the world to improve research culture

eLife is a non-profit organisation that receives financial support and strategic guidance from the Howard Hughes Medical Institute, the Knut and Alice Wallenberg Foundation, the Max Planck Society and Wellcome. eLife Sciences Publications Ltd is publisher of the open-access eLife journal (ISSN 2050-084X).

Related links